Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 191 - 200 of 200 for wx. (0.07 seconds)

WuXi PharmaTech has broken ground on a $100 million R&D...
Tigermed Consulting will add pre-clinical capability to...
WuXi PharmaTech has completed construction of a new...
Aslan Pharma of Singapore acquired global rights to...
WuXi PharmaTech formed a clinical biomarker partnership...
Crown Bioscience, a preclinical US-China CRO, closed a...
WuXi PharmaTech has begun high-potency active...
The $20 million China medical device JV formed by...
Steven Yang, PhD, the new COO of WuXi AppTech, may be the...
Luye Pharma priced its Hong Kong IPO at the top end of...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here